Vyne Therapeutics
Israel - Ness ZionaBiotechnology
Focus: Vyne Therapeutics is an Israel-based small-molecule biotech focused on dermatology, immunology, and respiratory indications with a pipeline spanning topical foams, oral tablets, and targeted therapies. The company operates as a mid-stage clinical-focused biotech with no reported commercial products.
Profile data last refreshed 3h ago · AI intelligence enriched 1w ago
Open Jobs
0
About Vyne Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Vyne Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Vyne Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
1/9 — Limited
Company HealthStrong
Pipeline
Late-stage
9 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
FMX101 vehicle
Acne VulgarisClinical Trials (1)
NCT03743038A Study Comparing Two Topicals in the Treatment of Acne Vulgaris
Phase 1Help build intelligence for Vyne Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.